BRK-B vs FULT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FULT presents a stark contrast between deep value and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the stock trades at a significant discount to both its Graham Number ($29.29) and Intrinsic Value ($61.36), the bearish technical trend and insider selling suggest caution. Strong earnings growth (46.5% YoY) and a consistent track record of beating estimates provide a bullish counter-narrative, but the low health score indicates underlying operational or financial instability. Overall, it is a high-value play with concerning health metrics.
Compare Another Pair
Related Comparisons
BRK-B vs FULT: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Fulton Financial Corporation (FULT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.